Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: J Ren Nutr. 2019 Jan 21;29(5):428–437. doi: 10.1053/j.jrn.2018.11.002

Figure 2.

Figure 2

Percentage of patients achieving serum phosphorus ≤5.5 mg/dL stratified by baseline phosphate binder type. Figure does not include 25 patients who switched between sevelamer, calcium acetate, and/or lanthanum carbonate at baseline and those on magnesium carbonate. CaAc, calcium acetate; LC, lanthanum carbonate; Sev, sevelamer; SO, sucroferric oxyhydroxide.